Hormonal therapy combined with radiotherapy in locally advanced prostate cancer

Reports of Practical Oncology and Radiotherapy

Volumn 7, Issue 4, 2002, Pages 157-163

  Milecki, Piotr ^a   Kwias, Zbigniew ^b  

^a Great Poland Cancer Centre   (Poland)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Combined treatment; Hormonal therapy; Prostate cancer; Radiotherapy

Indexed keywords

EID: 78049381774     PISSN: 15071367     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1507-1367(02)70990-5     Document Type: Article

References (30)

1. Chodak GW, Thisted RA, Gerber GS, Johansson JE, Adolfsson J, Jones GW, et al. Results of conservative management of clinically localized prostate cancer. N Engl J Med 1994; 330:242-8.
2. Catalona WJ. Surgical management of prostate cancer. Cancer 1995;75: 1903-8.
3. Shipley WU, Thames HD, Sandler HM, Hanks GE, Zietman AL, Perez CA, et al. Radiation therapy for clinically localized prostate cancer. A multi-institutional pooled analysis. JAMA 1999;281:1598-604.
4. Hanks GE, Hanlon AL, Schulthesiss TE, Pinover WE, Movsas B, Epstein BE, et al. Dose escalation with 3D conformal treatment: Five-year outcomes, treatment optimization, and future directions. Int J Radiat Oncol Biol Phys 1998;41:501-10
5. Zelefsky MJ, Leibel SA, Gaudin PB, Kutcher GJ, Fleshner NE, Ventakramen ES, et al. Dose escalation with threedimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys 1998;41: 491-500.
6. Huggins C, Hodges C. Studies on prostatic cancer: The effect of castration, of estrogen, and androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res 1941;1: 293-7.
7. Garnick MB. Hormonal therapy in the management of prostate cancer: from Huggins to the present. Urology 1997 (supp 3A);49:5-15.
8. McConnell JD. Physiologic basis of endocrine therapy for prostatic cancer. Urol Clin North Am 1991;18:1-7.
9. Janknegt RA, Abbou CC, Bartoletti R. Orchiectomy and Anandron (nilutamide) or placebo as treatment of metastatic prostate cancer in a multinational doubleblinded randomized trial. J Urol 1993;149: 119-30.
10. Soloway M, Sharifi R, Wajsman Z, McLeod D, Wood DP Jr, Puras-Baez A. Randomized prospective study comparing radical prostatectomy alone versus radical prostatectomy preceded by androgen blockade in clinical stage B2 (T2bNxM0) prostate cancer. J Urol 1995;154:424-8.
11. Aus G, Abrahamsson PA, Ahlgren G, Hugosson J, Lundberg S, Schain M, et al. Hormonal treatment before radical prostatectomy: A 3-year follow-up. J Urol 1998; 159:2016-7.
12. Zelefsky MJ, Harrison A. Neoadjuvant androgen ablation prior to radiotherapy for prostate cancer: reducing the potential morbidity of therapy. Urology 1997;49(suppl 3 A):38-45.
13. Marcenaro M, Sanguineti G, Franzone P, Corvo R, et al. Neoadjuvant androgen deprivation and prostate gland shrinkage during conformal radiotherapy. Int J Radiat Oncol Biol Phys 2001;51(ASTRO): 18-9.
14. Eulau SM, Corn BW. Combinations of hormones and local therapies in locally advanced prostate carcinoma. Oncology 1996;10:1193-202.
15. Movsas B, Chapman JD, Hanlon AL, Horowitz EM, Pinover WH, Greenberg RE, et al. Hypoxic regions exist in human prostate carcinoma. Urology 1999;53: 11-8.
16. Cvetkovic D, Movsas B, Dicker AP, Hanlon AL, Greenberg RE, Chapman JD, et al. Increased hypoxia correlates with increased expression of the angiogenesis marker vascular endothelial growth factor in human prostate cancer. Urology 2001; 57:821-5.
17. Pollack A, Salem N, Ashoori F, Hachem P, et al. Lack of prostate cancer radiosensitization androgen deprivation. Int J Radiat Biol Phys Oncol 2001;51:1002-7.
18. Zietman AL, Prince EA, Nakfoor BM, Shipley WH. Neoadjuvant androgen supperssion with radiation in the management of locally advanced adenocarcinoma of the prostate: experimental and clinical results. Urology 1997;49 (3A suppl): 74-83.
19. Zagars GK, Johnson DE, von Eschenbach AC, Hussay DH. Adjuvant estrogen following radiation therapy for stage C adenocarcinoma of the prostate: Longterm results of a prospective randomized study. Int J Radiat Oncol Biol Phys 1988; 14:1085-91.
20. Pilepich MV, Krall JM, John MJ, Rubin P, Porter AT, Marcial VA, et al. Hormonal cytoreduction in locally advanced carcinoma of the prostate treated with definitive radiotherapy: Preliminary results of RTOG 83-07. Int J Radiat Oncol Biol Phys 1989;16:813-7.
21. Pilepich MV, Caplan R, Byhart RW, Lawton CA, Gallagher NJ, Mesic JB, et al. Phase III trial of androgen supression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: Report of Radiation Oncology Group Protocol 85-31. J Clin Oncol 1997;15:1013-21.
22. Pilepich MV, Winter K, Russell AH Phase III Radiation Therapy Oncology Group (RTOG) trial 86-10 of androgen deprivation before and during radiotherapy in locally advanced carcinoma of the prostate (abstract 1185). Proc Am Soc Clin Onciol 1998;17:308a.
23. Bolla M, Gonzalez D, Warde P, Dubois JB, Mirimanoff RO, Storme G, et al. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and gosorelin. N Engl J Med 1997,337:295-300.
24. Laverdiere J, Gomez JL, Cusan L, Suburu ER, Diamond P, Lernay M, et al. Beneficial effect of combined therapy administered prior and following external beam radiation therapy in localized prostate cancer. Int J Radiat Biol Phys 1997; 37:247-52.
25. Hanks GE, Lu JD, Machtay M, et al. RTOG protocol 92-02: a phase III trial of the use of long term total androgen supression following neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate. Int J Radiat Oncol Biol Phys. ASTRO 2000;48:3,112.
26. D'Amico AV, Schultz D, Loffredo M, Dugal R, Hurwitz M, Kaplan I, et al. Biochemical outcome following external beam radiation therapy with or without androgen suppression therapy for men with clinically localized prostate cancer. JAMA 2000;284:1280-3.
27. Singer PA, Tasch ES, Stocking C, Rubin S, Siegler M, et al. Sex or survival: trade offs between quality and quantity of life. J Clin Oncol 1991;9:328-34.
28. Daniell HW. Osteoporosis after orchiectomy for prostate cancer. J Urol 1997;157: 439-44.
29. Daniell HW, Tam EW. Increased testicular atrophy following prostate bed radiation therapy for prostate carcinoma. Cancer 1998;83:1174-9.
30. Gee WF, Holtgrewe HL, Albersten PC, Litwin MS, Manyak MJ, et al. Practice trends in the diagnosis and management of prostate cancer in the United States. J Urol 1995;...:207-8.